Browse EX-10 agreements

​

COMMON STOCK PURCHASE AGREEMENT

Dated as of June 10, 2026

by and between

SWARMER, INC

and

LUCID CAPITAL MARKETS, LLC

​

​

---

​

Table of Contents

​

​

​

​

​

Page

Article I DEFINITIONS

1

​

​

Article II PURCHASE AND SALE OF COMMON STOCK

2

Section 2.1.

Purchase and Sale of Stock

2

Section 2.2.

Closing Date; Settlement Dates

2

Section 2.3.

Initial Public Announcements and Required Filings

2

​

​

​

Article III PURCHASE TERMS

3

Section 3.1.

VWAP Purchases

3

Section 3.2.

Intraday VWAP Purchases

4

Section 3.3.

Settlement

5

Section 3.4.

Compliance with Rules of Trading Market.

6

Section 3.5.

Beneficial Ownership Limitation

7

​

​

​

Article IV REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE INVESTOR

7

Section 4.1.

Organization and Standing of the Investor

7

Section 4.2.

Authorization and Power

7

Section 4.3.

No Conflicts

8

Section 4.4.

Investment Purpose

8

Section 4.5.

Accredited Investor Status

8

Section 4.6.

Reliance on Exemptions

8

Section 4.7.

Information

9

Section 4.8.

…

PLACEMENT AGENCY AGREEMENT

 

FT Global Capital, Inc.

1688 Meridian Avenue, Suite 700

Miami Beach, FL 33139

June 9, 2026

 

Ladies and Gentlemen:

 

This letter (this “Agreement”) constitutes the agreement between Mingteng International Corporation Inc. (the “Company”) and FT Global Capital, Inc. (“FT Global” or the “Placement Agent”) pursuant to which FT Global shall serve as the exclusive placement agent for the Company, on a reasonable “best efforts” basis, in connection with the proposed offer and sale (the “Offering”) by the Company of its Securities (as defined Section 3 of this Agreement) (the “Services”). The Company expressly acknowledges and agrees that FT Global’s obligations hereunder are on a reasonable “best efforts” basis only and that the execution of this Agreement does not constitute a commitment by FT Global to purchase the Securities and does not ensure the successful placement of the Securities or any portion thereof or the success of FT Global with respect to securing any other financing on behalf of the Company.

 

…

EXECUTION COPY

 

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase Agreement (this “Agreement”) is dated as of June 9, 2026, between One and Mingteng International Corporation Inc., a Cayman Islands exempted company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

 

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Securities Act”), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

 

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

ARTICLE I. DEFINITIONS

…

EXHIBIT 10.1 

 

MUTUAL RELEASE, SETTLEMENT, AND TERMINATION AGREEMENT

 

Visium Technologies, Inc. and ConnexUS AI Inc.

 

This Mutual Release, Settlement, and Termination Agreement (this “Agreement”) is entered into as of June __, 2026 (the “Effective Date”), by and between:

 

VISIUM TECHNOLOGIES, INC., a Florida corporation with principal executive offices at 4094 Majestic Lane, Suite 360, Fairfax, VA 22033 (“Visium” or “Company”); and

 

CONNEXUS AI INC., a Delaware corporation with principal place of business at 3301 N University Drive, Coral Springs, FL 33065 (“ConnexUS” or “Service Provider”).

 

RECITALS

 

A. Visium and ConnexUS previously entered into that certain Amended and Restated Letter of Intent (the “LOI”) for the proposed acquisition of ConnexUS by Visium.

 

B. The Board of Directors of Visium has determined, in the exercise of its business judgment under Fla. Stat. § 607.0830, that the ConnexUS incubation has failed and that termination of the LOI is in the best interests of Visium and its shareholders.

…

SENSEI BIOTHERAPEUTICS, INC.

2026 EQUITY INCENTIVE PLAN

ADOPTED BY THE BOARD OF DIRECTORS: APRIL 10, 2026

APPROVED BY THE STOCKHOLDERS: JUNE 10, 2026

1. GENERAL.

(a) Successor to Prior Plan. The Plan is the successor to the Prior Plan. As of the Effective Date, (i) no additional awards may be granted under the Prior Plan; and (ii) all outstanding awards granted under the Prior Plan will remain subject to the terms of the Prior Plan. All Awards granted under this Plan will be subject to the terms of this Plan.

(b) Plan Purpose. The Company, by means of the Plan, seeks to secure and retain the services of Employees, Directors and Consultants, to provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and to provide a means by which such persons may be given an opportunity to benefit from increases in value of the Common Stock through the granting of Awards.

…

SENSEI BIOTHERAPEUTICS, INC.

2026 EMPLOYEE STOCK PURCHASE PLAN

ADOPTED BY THE BOARD OF DIRECTORS: APRIL 10, 2026

APPROVED BY THE STOCKHOLDERS: JUNE 10, 2026

1. GENERAL; PURPOSE.

(a) The Plan provides a means by which Eligible Employees of the Company and certain Designated Companies may be given an opportunity to purchase shares of Common Stock. The Plan permits the Company to grant a series of Purchase Rights to Eligible Employees under an Employee Stock Purchase Plan. In addition, the Plan permits the Company to grant a series of Purchase Rights to Eligible Employees that do not meet the requirements of an Employee Stock Purchase Plan.

…

Execution Copy

CREDIT AGREEMENT

DATED AS OF JUNE 10, 2026,

AMONG

DELL TECHNOLOGIES INC.,

AS PARENT,

DENALI INTERMEDIATE INC.,

AS HOLDINGS,

DELL INC.,

AS THE COMPANY,

DELL INTERNATIONAL L.L.C.,

AS A BORROWER,

EMC CORPORATION,

AS A BORROWER,

JPMORGAN CHASE BANK, N.A.,

AS ADMINISTRATIVE AGENT,

AND

THE OTHER LENDERS AND L/C ISSUERS PARTY HERETO,

 

 

JPMORGAN CHASE BANK, N.A., BANK OF AMERICA, N.A., BARCLAYS BANK PLC, CITIBANK, N.A.

GOLDMAN SACHS BANK USA, WELLS FARGO SECURITIES, LLC AND HSBC BANK USA, N.A.,

AS JOINT LEAD ARRANGERS AND JOINT BOOKRUNNERS,

BANK OF AMERICA, N.A., BARCLAYS BANK PLC, CITIBANK, N.A., GOLDMAN SACHS BANK USA,

WELLS FARGO BANK, N.A. AND HSBC BANK USA, N.A.,

AS SYNDICATION AGENTS,

BNP PARIBAS SECURITIES CORP., DEUTSCHE BANK SECURITIES INC., MIZUHO BANK, LTD.,

MORGAN STANLEY SENIOR FUNDING, INC., MUFG BANK, LTD., PNC BANK, NATIONAL

ASSOCIATION, RBC CAPITAL MARKETS, SOCIÉTÉ GÉNÉRALE, TD SECURITIES (USA) LLC, THE

BANK OF NOVA SCOTIA AND UBS AG, STAMFORD BRANCH,

AS DOCUMENTATION AGENTS

 

 

 

---

…

June 8, 2026

Anna Eramo, M.D.

Dear Anna:

This letter sets forth the substance of the separation agreement (the “Agreement”), by and between LB Pharmaceuticals Inc (the “Company”) and you, which confirms our mutual agreement to end your employment with the Company and sets forth our agreement as to the manner in which your employment with the Company will be amicably closed out.

1. SEPARATION. Your last day of work with the Company and your employment termination date will be June 15, 2026 (the “Separation Date”). You are hereby deemed to have resigned, effective as of the Separation Date, all positions, titles, duties, authorities, and responsibilities at or with the Company and its affiliates, including any relationships as an employee, officer or director with the Company or any of its affiliates, and you agree to execute all additional documents and take such further steps as may reasonably be required to give effect to such resignation(s).

…

Document

Exhibit 10.1

AMENDMENT NO. 3

TO

WHEELS UP EXPERIENCE INC. 2021 LONG-TERM INCENTIVE PLAN,

AS AMENDED AND RESTATED APRIL 1, 2023

This Amendment No. 3 (this “Amendment”) to the Wheels Up Experience Inc. 2021 Long-Term Incentive Plan, as amended and restated April 1, 2023 (as amended by Amendment No. 1 thereto, effective as of June 6, 2024, and as further amended by Amendment No. 2 thereto, effective as of June 10, 2025, collectively, the “Plan”), is adopted by the Board of Directors of Wheels Up Experience Inc. (the “Company”) on March 31, 2026, to be effective upon approval (the “Amendment Effective Time”) of this Amendment by the Company’s stockholders at a duly called and noticed meeting of the Company’s stockholders or by written consent of the Company’s stockholders, in each case in accordance with the Company’s Amended and Restated Certificate of Incorporation, dated November 15, 2023, Amended and Restated By-Laws, effective as of November 15, 2023, and the General Corporation Law of the State of Delaware. Capitalized terms used herein but not otherwise defined here

…

RAMACO RESOURCES, INC.

LONG-TERM INCENTIVE PLAN

 

(As amended and restated June 10, 2026)

 

1. Purpose. The purpose of the Ramaco Resources, Inc. Long-Term Incentive Plan (the “Plan”) is to provide a means through which (a) Ramaco Resources, Inc., a Delaware corporation (the “Company”), and its Affiliates may attract, retain and motivate qualified persons as employees, directors and consultants, thereby enhancing the profitable growth of the Company and its Affiliates and (b) persons upon whom the responsibilities of the successful administration and management of the Company and its Affiliates rest, and whose present and potential contributions to the Company and its Affiliates are of importance, can acquire and maintain stock ownership or other awards tied to the performance of the Company, thereby strengthening their concern for the Company and its Affiliates. Accordingly, the Plan provides for granting Options, SARs, Restricted Stock, Restricted Stock Units, Stock Awards, Dividend Equivalents, Other Stock-Based Awards, Cash Awards, Substitute Awards, Perfor

…

Exhibit 10.1

 

ASTRANA HEALTH, INC. AMENDED AND RESTATED 2024 EQUITY INCENTIVE PLAN

 

1.             Establishment, Purpose, Duration.

 

(a)           Establishment; Amendment and Restatement. Astrana Health, Inc. (the “Company”) originally established the Astrana Health, Inc. 2024 Equity Incentive Plan, effective as of February 28, 2024 (the “Effective Date”), and the Plan was originally approved by the stockholders of the Company at the 2024 Annual Meeting of Stockholders. The Plan was amended and restated in its entirety effective as of March 26, 2025, and was most recently approved by the stockholders of the Company at the 2025 Annual Meeting of Stockholders. The Plan is hereby further amended and restated in its entirety as set forth herein, effective as of March 25, 2026 (the “2026 Restatement Date”), subject to approval of the amended and restated Plan by the stockholders of the Company at the 2026 Annual Meeting of Stockholders. Definitions of certain capitalized terms used in the Plan are contained in Section 2 hereof.

…

SYNDAX PHARMACEUTICALS, Inc.

2026 Equity Incentive Plan

Adopted by the Board of Directors: April 30, 2026 Approved by the Stockholders: June 10, 2026

 

General.

(a)

Successor to and Continuation of Prior Plan. The Plan is the successor to and continuation of the Prior Plan. As of the Adoption Date, (i) no additional awards may be granted under the Prior Plan; (ii) any Returning Shares will become available for issuance pursuant to Awards granted under this Plan; and (iii) all outstanding awards granted under the Prior Plan will remain subject to the terms of the Prior Plan (except to the extent such outstanding awards result in Returning Shares that become available for issuance pursuant to Awards granted under this Plan). All Awards granted under this Plan will be subject to the terms of this Plan.

(b)

…